SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (2019)1/25/2017 10:09:18 AM
From: DewDiligence_on_SI  Read Replies (2) | Respond to of 3559
 
Ex-US Lucentis had slightly negative QoQ pricing with positive volume growth, according to NVS CC.



To: Miljenko Zuanic who wrote (2019)4/25/2017 11:44:29 AM
From: Miljenko Zuanic  Read Replies (1) | Respond to of 3559
 
From NVS, Continue slow decline in Lucentis ex-US sale (445 v 452-4Q, helped bit from strong $ in 1Q), will see where Roche stand in US?